J 2017

MitraClip: Catheter-based treatment of mitral regurgitation

ONDRÚŠ, Tomáš, Martin PENICKA, Martin KOTRC, Marc VANDERHEYDEN, Josef BARTUNEK et. al.

Basic information

Original name

MitraClip: Catheter-based treatment of mitral regurgitation

Name in Czech

MitraClip: katetrizační léčba mitrální regurgitace

Authors

ONDRÚŠ, Tomáš (703 Slovakia, guarantor, belonging to the institution), Martin PENICKA (56 Belgium), Martin KOTRC (203 Czech Republic), Marc VANDERHEYDEN (56 Belgium) and Josef BARTUNEK (56 Belgium)

Edition

Cor et Vasa, Brno, Česká kardiologická společnost, 2017, 0010-8650

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30201 Cardiac and Cardiovascular systems

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

RIV identification code

RIV/00216224:14110/17:00097417

Organization unit

Faculty of Medicine

DOI

UT WoS

000410029900016

Keywords in English

Catheter-based treatment; MitraClip; Mitral regurgitation

Tags

Tags

International impact, Reviewed
Změněno: 13/3/2018 17:36, Soňa Böhmová

Abstract

V originále

Mitral regurgitation (MR) is the second most prevalent heart valve disease requiring surgery. Despite the evidence of unfavourable prognosis, around half of patients with severe MR are not referred for surgery due to high per-operative risk. MitraClip (Abbott Vascular-Structural Heart, Menlo Park, California, United States) implantation is an emerging percutaneous technique with edge-to-edge MV repair inspired by the Alfieri surgery. Favourable safety profile together with improvement of functional status and decrease of MR severity in high-surgical-risk patients have been demonstrated in randomized clinical trials and “real-world” registries for both primary and secondary MR. Our own data confirmed its safety and efficacy comparing to minimally invasive MV surgery in treatment of functional MR in population with severe systolic heart failure.